SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES
๐ฎ๐ทIran
- Country
- ๐ฎ๐ทIran
- Ownership
- Private
- Established
- 1961-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.sbmu.ac.ir/
Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD
Phase 3
- Conditions
- Neovascular Age-Related Macular Degeneration
- Interventions
- First Posted Date
- 2006-08-31
- Last Posted Date
- 2008-06-26
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Registration Number
- NCT00370370
- Locations
- ๐ฎ๐ท
Hamid Ahmadieh, MD, Tehran, Iran, Islamic Republic of
Intravitreal Triamcinolone for Acute Branch Retinal Vein Occlusion
Phase 2
Completed
- Conditions
- Branch Retinal Vein Occlusion
- First Posted Date
- 2006-08-31
- Last Posted Date
- 2008-06-17
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 30
- Registration Number
- NCT00370266
- Locations
- ๐ฎ๐ท
Alireza Ramezani, MD, Tehran, Iran, Islamic Republic of
Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical Trial
Phase 3
- Conditions
- Diabetic Macular Edema
- First Posted Date
- 2006-08-31
- Last Posted Date
- 2007-03-13
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Registration Number
- NCT00370422
- Locations
- ๐ฎ๐ท
Hamid Ahmadieh, MD, Tehran, Iran, Islamic Republic of
Combined PDT and Intravitreal Bevacizumab vs Combination of PDT, Intravitreal Bevacizumab and Triamcinolone for Neovascular AMD
Phase 3
- Conditions
- Neovascular Age-Related Macular Degeneration
- First Posted Date
- 2006-08-31
- Last Posted Date
- 2006-11-14
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Registration Number
- NCT00370539
- Locations
- ๐ฎ๐ท
Hamid Ahmadieh, MD, Tehran, Iran, Islamic Republic of
Efficacy of Oral Colchicine in Prevention of Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment
Phase 3
- Conditions
- Rhegmatogenous Retinal Detachment
- First Posted Date
- 2006-08-31
- Last Posted Date
- 2006-10-09
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Registration Number
- NCT00370201
- Locations
- ๐ฎ๐ท
Hamid Ahmadieh,MD, Tehran, Iran, Islamic Republic of
A Randomized, Placebo-Controlled Clinical Trial of Intravitreal Triamcinolone for Refractory Diabetic Macular Edema
Phase 2
Completed
- Conditions
- Diabetic Macular Edema
- First Posted Date
- 2006-08-30
- Last Posted Date
- 2007-02-28
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 76
- Registration Number
- NCT00369863
- Locations
- ๐ฎ๐ท
Labbafinejad Medical Center, Tehran, Iran, Islamic Republic of
The Efficacy of 308nm Excimer Laser in White Striae
Phase 1
Completed
- Conditions
- White StriaeExcimer Laser
- First Posted Date
- 2006-08-08
- Last Posted Date
- 2008-02-20
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 10
- Registration Number
- NCT00361361
- Locations
- ๐ฎ๐ท
Skin Research Center, Shaheed Beheshti Medical University, Tehran, Iran, Islamic Republic of
Q-Switched Nd:YAG in Macular Amyloidosis
Phase 1
Completed
- Conditions
- Macular Amyloidosis
- First Posted Date
- 2006-07-18
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 20
- Registration Number
- NCT00353392
- Locations
- ๐ฎ๐ท
Skin Research Center, Shaheed Beheshti Medical University, Tehran, Iran, Islamic Republic of
The Efficacy of Pulsed Dye Laser in Dermatophytosis
Phase 1
Completed
- Conditions
- Cutaneous DermatophytosisPulsed Dye Laser
- First Posted Date
- 2006-07-13
- Last Posted Date
- 2008-02-20
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 10
- Registration Number
- NCT00351897
- Locations
- ๐ฎ๐ท
Skin Research Center, Shaheed Beheshti Medical University, Tehran, Iran, Islamic Republic of
ยฉ Copyright 2025. All Rights Reserved by MedPath